Total Revenue
International Flavors & Fragrances Total Revenue increased by 5.9% to $2.74B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.6%, from $2.84B to $2.74B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows relatively stable performance with a -1.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.09B | $3.07B | $3.03B | $3.23B | $3.31B | $3.06B | $2.84B | $3.03B | $2.93B | $2.82B | $2.70B | $2.90B | $2.89B | $2.93B | $2.77B | $2.84B | $2.76B | $2.69B | $2.59B | $2.74B |
| QoQ Change | — | -0.6% | -1.3% | +6.4% | +2.5% | -7.4% | -7.1% | +6.4% | -3.2% | -3.7% | -4.1% | +7.3% | -0.3% | +1.2% | -5.3% | +2.6% | -2.8% | -2.5% | -3.9% | +5.9% |
| YoY Change | — | — | — | — | +7.1% | -0.3% | -6.2% | -6.2% | -11.4% | -7.9% | -5.0% | -4.2% | -1.4% | +3.7% | +2.5% | -1.9% | -4.3% | -7.9% | -6.6% | -3.6% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Food Ingredients | — | — | — | $796.00M | $850.00M | $830.00M | $802.00M | $839.00M |
| Taste | — | — | — | $627.00M | $631.00M | $635.00M | $588.00M | $656.00M |
| Scent | $603.00M | $613.00M | $578.00M | $614.00M | $603.00M | $652.00M | $610.00M | $651.00M |
| Health & Biosciences | $556.00M | $568.00M | — | $540.00M | $577.00M | $577.00M | — | — |
| Nourish | $1.48B | $1.49B | $1.41B | $627.00M | $631.00M | $635.00M | — | — |
| Pharma Solutions | $273.00M | $278.00M | $248.00M | $266.00M | $103.00M | — | — | — |
| Total | $2.89B | $2.93B | $2.77B | $2.84B | $2.76B | $2.69B | $2.59B | $2.74B |
Nourish, Pharma Solutions were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Geographic Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Net sales attributed to all foreign countries | $2.07B | $2.09B | — | $2.04B | $2.00B | $1.96B | — | $2.00B |
| Europe, Africa and Middle East | $972.00M | $964.00M | $927.00M | $952.00M | $953.00M | $933.00M | $889.00M | $949.00M |
| North America | $876.00M | $886.00M | $812.00M | $868.00M | $803.00M | $779.00M | $745.00M | $788.00M |
| Greater Asia | $681.00M | $694.00M | $674.00M | $670.00M | $647.00M | $617.00M | $612.00M | $656.00M |
| Latin America | $360.00M | $381.00M | $358.00M | $353.00M | $361.00M | $365.00M | $343.00M | $348.00M |
| Total | $2.89B | $2.93B | $2.77B | $2.84B | $2.76B | $2.69B | $2.59B | $2.74B |
Total Revenue at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's total revenue?
- International Flavors & Fragrances (IFF) reported total revenue of $2.74B in Q1 2026.
- How has International Flavors & Fragrances's total revenue changed year-over-year?
- International Flavors & Fragrances's total revenue decreased by 3.6% year-over-year, from $2.84B to $2.74B.
- What is the long-term trend for International Flavors & Fragrances's total revenue?
- Over 4 years (2021 to 2025), International Flavors & Fragrances's total revenue has grown at a -1.7% compound annual growth rate (CAGR), from $11.66B to $10.89B.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.